Latin America is increasingly appealing for clinical research due to its large, diverse patient populations and significant disease burdens in areas like oncology and infectious disease. This attracts sponsors seeking quicker enrollment and comprehensive data. However, CRO setup and upgradation in Brazil, Peru, Chile, and Argentina requires careful planning, including an understanding of country-specific regulatory requirements, ethics review processes, quality standards, and operational challenges. This guide outlines the key steps involved in establishing a new contract research organization (CRO) or upgrading existing operations, and how Zenovel can support this process.
Sponsors are expanding trial locations beyond traditional geographies due to the benefits of faster patient recruitment, increased population diversity, and enhanced cost efficiency. Latin America presents these advantages, aided by favorable time zones for North American sponsors and a growing number of experienced sites. However, the four countries discussed have unique regulatory, ethics, import, and data protection frameworks. Successful CRO setup and upgradation services in Latin America requires tailored strategies for each country, rather than treating the region as a single market, to avoid delays.
Step 1: Choose your entry model
To operate in a new region, decide on the following models: 1) Establishing a local legal entity offers direct control, local credibility, and compliance obligations. 2) Partnering with a local CRO provides quicker setup and shared control, reducing fixed costs. 3) A hybrid model combines a small local team with a specialized partner for regulatory and monitoring support, which is often beneficial for initial scaling and can transition to a full local presence as study volume increases.
Step 2: Understand the regulatory landscape country by country
The document emphasizes the importance of verifying current rules and timelines with the relevant authority or a local regulatory expert prior to submission.
- Brazil leads clinical research in the region, characterized by a structured process involving two review tracks: one by the health regulator (ANVISA) and another by ethics bodies via Plataforma Brasil. Recent legislative changes aim to enhance the efficiency of this framework. Key considerations include the necessity for Portuguese documentation, import licensing for products and samples, and compliance with the LGPD for participant data management.
- Peru’s clinical trial oversight is conducted by the National Institute of Health (INS) alongside accredited ethics committees. Trials require national registration and compliance with regulations outlining the responsibilities of sponsors, investigators, and sites. While Peru presents strong enrollment opportunities, varying site capacities necessitate detailed feasibility assessments and initial institutional engagement. Additionally, documentation must be in Spanish, in line with local data protection laws.
- Chile‘s Institute of Public Health (ISP) oversees the authorization of clinical studies for pharmaceutical products, with ethics committees reviewing protocols and informed consent. The country benefits from a stable regulatory environment and effective hospital networks. However, with a recent update to its personal data protection framework, data governance should be considered early in the planning process, and the smaller population size necessitates realistic feasibility assessments.
- Argentina‘s national regulator (ANMAT) oversees clinical pharmacology studies, necessitating ethics reviews by independent committees, with jurisdictional variations. The country has a robust history of clinical research and skilled investigators. Key considerations include the impact of economic and import conditions on logistics and timelines, making early planning for investigational products and supply chain crucial, alongside adherence to national data protection laws.
Step 3: Build a quality system aligned with global standards
Sponsors expect CROs to adhere to international standards, regardless of local regulations. Essential foundational elements include: alignment with ICH GCP standards, particularly the updated E6 revisions, alongside a comprehensive quality management system covering SOPs, training documentation, deviation management, and Corrective and Preventive Action (CAPA) processes. CROs should maintain qualified personnel including monitors, regulatory specialists, project managers, data managers, medical writers, and Quality Assurance (QA) staff, all with defined training and role descriptions. Additionally, effective vendor and site oversight entails thorough qualification, ongoing performance assessments, and clear contractual obligations. Finally, to ensure inspection readiness, CROs should conduct mock inspections and Trial Master File (TMF) reviews prior to any sponsor audits or regulatory inspections.
Step 4: Build your people, sites and infrastructure
A CRO’s strength relies on its operational network, which includes a validated site and investigator database, bilingual and multilingual capabilities for effective communication, in-country regulatory affairs expertise to accelerate study start-ups, a compliant technology stack (CTMS, eTMF, EDC), and robust logistics for handling investigational products and samples.
Step 5: Plan for data protection and privacy
Each country has unique data protection laws, necessitating a clear legal basis for cross-border data transfer, consent language tailored to these laws, and suitable contractual safeguards. Integrate privacy-by-design principles into informed consent forms, data flows, and vendor agreements from the outset rather than as an afterthought.
CRO Setup and Upgradation Services in Latin America: Improving Clinical Research Operations
Many CROs in Latin America aim to transition from being functional service providers to preferred strategic partners through CRO setup and upgradation, focusing on five key areas: improving regulatory speed through standardized submission packages, adopting risk-based quality management with targeted monitoring, leveraging digital and decentralized capabilities like eConsent and remote monitoring, deepening expertise in select therapeutic areas, and transparently sharing performance metrics such as enrollment and inspection outcomes with sponsors.
Common pitfalls to avoid
Common pitfalls in international processes include assuming transferability without adaptation, underestimating import and customs timelines, weak feasibility leading to over-promised enrollment, neglecting translation and document localization, and delaying quality system readiness until an audit is scheduled.
Zenovel assists CROs and sponsors with CRO setup and upgradation across four regulatory environments, aiming to streamline the process and improve predictability where in-house expertise is limited.
- Market entry strategy: Selecting the right entry model and country sequence for your goals.
- Regulatory and ethics guidance: Submission planning and country-specific start-up support for Brazil, Peru, Chile and Argentina.
- Quality system development and upgrade: SOP frameworks, gap assessments, training programs and inspection readiness.
- Site and feasibility support: Identifying and qualifying investigators and sites with the right therapeutic and operational profile.
- Medical and regulatory writing: Protocols, consent forms, regulatory documents and localized, high-quality translations.
- Operational optimization: Process improvement, monitoring strategy and performance metrics to help establish and scale CROs.
Our aim is to assist you with CRO setup and upgradation services in Latin America, creating compliant, efficient, and credible operations while avoiding expensive trial and error.
Latin America rewards CROs that combine global quality standards with local regulatory insight. Brazil, Peru, Chile and Argentina each offer distinct strengths, and each requires its own approach. Whether you are entering the region for the first time or upgrading an operation already in place, the right planning and the right partner can make the difference between a slow, uncertain launch and a confident one.
Ready to build or strengthen your CRO presence in Latin America? Contact Zenovel to start the conversation.
